Radiomics in esophageal and gastric cancer.
Abdom Radiol (NY). 2018 Aug 16. doi: 10.1007/s00261-018-1724-8. [Epub ahead of print]
Sah BR1, Owczarczyk K1, Siddique M1, Cook GJR1,2, Goh V3,4,5.
Esophageal, esophago-gastric, and gastric cancers are major causes of cancer morbidity and cancer death. For patients with potentially resectable disease, multi-modality treatment is recommended as it provides the best chance of survival. However, quality of life may be adversely affected by therapy, and with a wide variation in outcome despite multi-modality therapy, there is a clear need to improve patient stratification. Radiomic approaches provide an opportunity to improve tumor phenotyping. In this review we assess the evidence to date and discuss how these approaches could improve outcome in esophageal, esophago-gastric, and gastric cancer.
Read Full Article Here: https://doi.org/10.1007/s00261-018-1724-8